Markus Essler

German Multicenter Study Investigating¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 832 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Biomimetic amplification of nanoparticle homing to tumors

Dmitri Simberg, Tasmia Duza, Ji Ho Park et al. · Proceedings of the National Academy of Sciences · 2007 · 468 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +17

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

Wolfgang Siess, Konrad J. Zangl, Markus Essler et al. · Proceedings of the National Academy of Sciences · 1999 · 405 citations · Full text

Medicine, Biochemistry, Cardiology +17

Thrombin Inactivates Myosin Light Chain Phosphatase via Rho and Its Target Rho Kinase in Human Endothelial Cells

Markus Essler, Mutsuki Amano, Hans-Joachim Kruse et al. · Journal of Biological Chemistry · 1998 · 351 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

Hojjat Ahmadzadehfar, Kambiz Rahbar, Stefan Kürpig et al. · EJNMMI Research · 2015 · 293 citations · Full text

Medicine, Nuclear Medicine, Oncology +17